Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,560 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07550075Recruiting
Support program for Korean American dementia caregivers
This study tests a virtual support program designed specifically for Korean American adults who care for family members with dementia. The program aims to help caregivers manage stress and learn practical caregiving skills through online classes.
Los Angeles, CaliforniaAges 18 years+ - NCT07539662Enrolling by invitation
Cord Blood Stem Cell Transplant for ALS
This trial tests whether a transplant of special cells from donated umbilical cord blood can help slow or improve symptoms of ALS (amyotrophic lateral sclerosis, also called Lou Gehrig's disease). The cells may help repair nerve damage and reduce disease progression.
TianjinAges 35–50 - NCT07505797Recruiting
Ultrasound imaging study for suspicious breast lesions
This study is testing a new ultrasound device (ATUSA) to see how well it can image breast lesions that have been classified as suspicious (BI-RADS 4 or 5). If you have a recent finding that needs further evaluation, this research might help improve detection methods.
Sacramento, CaliforniaAges 18–94 - NCT07493538RecruitingPhase 2
Blood stem cell transplant with lower-intensity chemo for blood cancers
This trial tests a stem cell transplant using milder chemotherapy (treosulfan and fludarabine) followed by a drug called cyclophosphamide to prevent graft-versus-host disease. It aims to make transplant safer for people with blood diseases who cannot handle standard high-dose chemotherapy.
Minneapolis, MinnesotaAges 2–75 - NCT05852418Recruiting
Registry study of devices, medicines, and care in ALS and SMA
This study collects information in a registry about assistive devices, medicines, and healthcare support for people with long-term neurological conditions like ALS and SMA. It may help researchers understand what treatments and supports are used and how they relate to patients’ needs over time.
BerlinAges 18 years+ - NCT07446114Recruiting
Brain-computer interface trial for ALS (Canada)
This trial tests a brain-computer interface (BCI) device that may help people with ALS or motor neuron disease regain some control over their environment. It involves implanting the device in a blood vessel in the brain.
Toronto, OntarioAges 18 years+ - NCT07434115RecruitingEarly Phase 1
Orthobiologics for muscle, bone, and joint problems
This study tests treatments using your body's own healing cells or proteins (called orthobiologics) for muscle, bone, and joint problems. It collects information through digital questionnaires on WhatsApp to see how these treatments work in real life.
Bento Gonçalves, Rio Grande do SulAges 18 years+ - NCT07425574Recruiting
Study on how Stargardt eye conditions progress in children and adults
This study observes how Stargardt disease and similar eye conditions change over time in children and adults. It aims to learn more about the disease progression to help develop future treatments.
Phoenix, ArizonaAges 6 years+ - NCT07417280Recruiting
Focused ultrasound for neurological disorders
This trial tests a gentle ultrasound treatment (LIFUS) for people with various brain conditions like epilepsy, tumours, or movement disorders. It aims to see if this non-invasive approach can help where other treatments are being used.
Toronto, OntarioAges 18–85 - NCT07391293Recruiting
Genetic aortic diseases and heart risks observational study
This study looks at people with genetic aortic diseases to understand risk factors for heart complications. By joining, you help researchers learn more about these conditions and how to better manage them.
MilanAges 14–60 - NCT07374913Recruiting
Study of COL4A1 and COL4A2 gene mutations
This study looks at people with a mutation in the COL4A1 or COL4A2 genes, which can cause problems in small blood vessels throughout the body. It aims to learn more about the condition and may also include family members who carry the mutation or who can serve as healthy controls.
Florence, FIAges Any age - NCT06781580Recruiting
Ergonomic program for competitive esports players
This study tests an ergonomic protocol designed to help competitive esports athletes avoid injuries and stay comfortable during long gaming sessions. It focuses on PC gamers who use a mouse and keyboard and are already on a team.
Las Vegas, NevadaAges 18 years+ - NCT07360938Recruiting
How inflammation affects drug processing
This study looks at how inflammation from conditions like diabetes, IBD, or kidney disease affects the way drugs work in the body. It may help improve dosing and safety for patients with these conditions.
Indianapolis, IndianaAges 12–99 - NCT00874783Recruiting
Testing nerve-cell growth from donated body cells
This trial uses donated body cells or small hair samples from people with neurological diseases (and healthy donors) to try to grow “nerve-like” cells for research. It may help scientists learn how to better study and treat different neurological conditions.
Jerusalem, IsraelAges 18 years+ - NCT07350395Recruiting
How steroids affect children with autoimmune conditions
This study talks to children and young people with autoimmune or inflammatory conditions (like juvenile arthritis) who have taken steroids in the past two years. It aims to understand how steroids impact their daily lives and feelings.
Bristol, North SomersetAges Up to 18 years - NCT07343297Recruiting
Ask questions about clinical trials
This study helps people learn about clinical trials and find out if they might be a good fit. It is for patients who are already getting treatment at a Karmanos or McLaren center and can read English well enough to complete surveys.
Bay City, MichiganAges 18 years+ - NCT07314736Recruiting
Study on values and ethics for ultra-rare diseases
This study aims to understand the perspectives of parents, caregivers, family members, and professionals involved with children who have ultra-rare genetic disorders. It uses interviews or focus groups to explore ethical and value-based questions.
Memphis, TennesseeAges Any age - NCT07304154RecruitingPhase 1
Study of KITE-363 for autoimmune nerve diseases
This trial tests a new treatment called KITE-363 for people with certain autoimmune nerve diseases, such as multiple sclerosis, myasthenia gravis, or chronic inflammatory demyelinating polyneuropathy, that have not responded well to standard therapies. The goal is to see if it is safe and effective.
Newport Beach, CaliforniaAges 18–75 - NCT07303582RecruitingPhase 4
Freezing nerves to ease pain from muscle tightness
This study tests if freezing specific nerves (cryoneurolysis) can reduce pain caused by muscle tightness (spasticity) after a brain or spinal cord injury, or from multiple sclerosis. It is for people who already get Botox injections for this pain.
OxfordAges 18 years+ - NCT07278960Recruiting
Study on improving care for children born through IVF
This study looks at how to better manage the health of children up to 3 years old who were conceived with help from fertility treatments like IVF or ICSI. Researchers want to see if new care plans can improve their development and health outcomes.
AlmatyAges birth–3 years - NCT07256704Recruiting
Hypnosis and attention for neurological conditions
This study looks at whether hypnosis can help improve attention in people with conditions like stroke, traumatic brain injury, or multiple sclerosis. It may help if you have trouble concentrating or focusing.
LucerneAges 18 years+ - NCT07249346RecruitingPhase 2
Preventing GVHD after stem cell transplant with three drugs
This trial tests a three-drug combination (cyclophosphamide, tacrolimus, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant. It is for people with certain blood cancers who have a matched donor and can tolerate high-dose chemotherapy.
Birmingham, AlabamaAges 18 years+ - NCT01293110Recruiting
Lower Urinary Problems Database at Zurich Hospitals
This trial is a research database study collecting information from people who have bladder and urine flow testing. It may help doctors better understand lower urinary tract problems over time.
Zurich, Canton of ZurichAges 18–90 - NCT07239791Recruiting
Does a low-dose medication affect how we learn?
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
ParisAges 18–39
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,560 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.